Founded in 2020 by Sachin and Shweta Darbarwar, Hyderabad-based ZeroHarm Sciences produces plant-derived health supplements using proprietary nano-formulation technology that converts nutrients into nano-sized particles for higher bioavailability and controlled release at lower dosages. The company positions itself as India’s first “Trust over Promise” health platform, pledging to demonstrate supplement efficacy through quantifiable consumer health outcomes. ZeroHarm fully controls its supply chain, sourcing medicinal plants through a network of more than 10,000 farmers across Northeast India and the Himalayas. It holds patents covering turmeric phytochemicals, iron-folic acid blends, carotenoid eye-health compounds, and synbiotic gut-health compositions. The portfolio spans 60+ SKUs addressing diabetes, heart health, joint care, immunity, gut health, oncology support, women’s wellness, and performance nutrition, and products are sold via its own site, Amazon, Flipkart, and quick-commerce channels. To date, the brand has served over 300,000 customers. Future plans include aggressive national brand building, scaling R&D and manufacturing, and expanding sales into the USA, UK, and Middle Eastern markets.

Total raised

$7M

Funding rounds

1

Latest round

Series A

Latest activity

Feb 2026